Renal Benefit of Dapagliflozin Therapy in Hyperfiltering Type 2 Diabetes Patients

被引：0
|
作者：
Baskoy, Gozde
Qin, Yuejuan
Cersosimo, Eugenio
Solis-Herrera, Carolina
Adams, John M., III
Defronzo, Ralph A.
Triplitt, Curtis L.
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-887-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
887-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Nephroprotective Effects of Dapagliflozin in Patients with Type 2 Diabetes
    Iijima, Yasuhiro
    Nakayama, Masafumi
    Miwa, Takashi
    Yakou, Fumiyoshi
    Tomiyama, Hirofumi
    Shikuma, Junpei
    Ito, Rokuro
    Tanaka, Akihiko
    Manda, Naoki
    Odawara, Masato
    [J]. INTERNAL MEDICINE, 2023, 62 (05) : 681 - 688
  • [22] Phase III study shows benefit of dapagliflozin in treating Type 2 diabetes
    不详
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (06) : 795 - 795
  • [23] Combination therapy with saxagliptin and dapagliflozin for the treatment of type 2 diabetes
    Williams, David M.
    Stephens, Jeffrey W.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (15) : 2373 - 2379
  • [24] Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment
    Fioretto, Paola
    Stefansson, Bergur V.
    Johnsson, Eva
    Cain, Valerie A.
    Sjostrom, C. David
    [J]. DIABETOLOGIA, 2016, 59 (09) : 2036 - 2039
  • [25] Combination therapy for type 2 diabetes: dapagliflozin plus metformin
    Tan, Xueying
    Hu, Jingbo
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (01) : 117 - 126
  • [26] Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment
    Paola Fioretto
    Bergur V. Stefansson
    Eva Johnsson
    Valerie A. Cain
    C. David Sjöström
    [J]. Diabetologia, 2016, 59 : 2036 - 2039
  • [27] Effect of dapagliflozin on renal and cardiac function in patients with type 2 diabetes and albuminuria: a randomised study
    Eickhoff, M. K.
    Olsen, F. J.
    Frimodt-Moller, M.
    Diaz, L. J.
    Jensen, M. T.
    Rossing, P.
    Persson, F.
    [J]. DIABETOLOGIA, 2018, 61 : S299 - S300
  • [28] Dapagliflozin reduces renal threshold for glucose excretion in type 2 diabetes
    DeFronzo, R. A.
    Hompesch, M.
    Kasichayanula, S.
    Liu, X.
    Hong, Y.
    Pfister, M.
    Morrow, L. A.
    Leslie, B. R.
    Boulton, D. W.
    Ching, A.
    LaCreta, F. P.
    Griffen, S. C.
    [J]. DIABETOLOGIA, 2012, 55 : S306 - S306
  • [29] Use of dapagliflozin as an add-on to insulin therapy in patients with suboptimally controlled type 2 diabetes
    Das, Gautam
    Surya, Ashutosh
    Abusahmin, Hussam
    [J]. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2018, 9 (08) : 269 - 270
  • [30] Dapagliflozin as Add-On Therapy in Asian Patients with Type 2 Diabetes Inadequately Controlled on Insulin
    Yang, Wenying
    Ma, Jianhua
    Li, Yiming
    Li, Yanbing
    Zhou, Zhiguang
    Kim, Jae Hyeon
    Zhao, June
    Ptaszynska, Agata
    [J]. DIABETES, 2017, 66 : A338 - A338
12345